Human GDF9 (Growth/Differentiation Factor 9) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-08235P
SDS-PAGE analysis of Human GDF9 (Growth/Differentiation Factor 9) - Recombinant Protein, CAT# BLT-08235P, showing >90% purity under 15% SDS-PAGE (Reduced)
Human GDF9 (Growth/Differentiation Factor 9) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-08235P
Regular price
$59500
$595.00
Sale price$41500
$415.00Save $180
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $962.50 Original price: |
| 1 mg | $1,746.00 Original price: |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Growth Differentiation Factor 9 (GDF9) Protein |
| Product Overview | This recombinant human Growth Differentiation Factor 9 (GDF9) protein includes amino acids 320-454aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in PBSprior to lyophilization. |
| Target Uniprot Id | O60383 |
| Recommended Name | Growth/differentiation factor 9 |
| Gene Name | GDF9 |
| Species | Human |
| Predicted Molecular Mass | 18 kDa |
| Expression System | E.coli |
| Expression Range | 320-454aa |
| Tag | N-6His |
| Purity | >90% |
| Formulation | Lyophilized |
| Buffer | PBS |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Cardiovascular |
| Target Function | Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells. |
| Subcellular Location | Secreted. |
| Protein Family | TGF-beta family |
| Associated Diseases | Altered GDF9 function may be involved in ovarian disorders. Rare variants in GDF9 have been found in patients with premature ovarian failure and mothers of dizygotic twins. |
| Tissue Specificity | Expressed in ovarian granulosa cells. Present in oocytes of primary follicles (at protein level). |
